Aquisição de Ocrelizumab 920 mg/23 ml Sol inj Fr 23 ml SC, ao abrigo do acordo quadro 2025/1303, para o ano 2026

ID 13549938 · Portal BASE
Price
Base Price
€538,648 .00
Effective Price
€538,648 .00 0.0%
Contract Details
Contract Type
Aquisição de bens móveis
Procedure
Ao abrigo de acordo-quadro (art.º 259.º)
CPV Code
33600000
Location
Portugal, Braga, Braga
Bidder Count
—
Winner
ROCHE FARMACEUTICA QUIMICA LDA
NIF 500233810
Company
Dates
Publication
23 Feb 2026
Celebration
29 Jan 2026
Contracting Entity
Unidade Local de Saúde de Braga, EPE
NIF 515545180
Public body
Data Source
Portal BASE
Api · synced 2026-04-17
Risk Flags
Score 40 · MEDIUM RISK
A2 · Late Publication
A2_PUBLICATION_AFTER_CELEBRATION
HIGH
Publication Date
23 Feb 2026
Signing Date
29 Jan 2026
Days Late
25
Rule
A2/A3 late publication: 25 days after signing (threshold: 10)
Detected 2026-03-06